Method and compositions for controlling pain, depression and sedation
Patent 4698342 Issued on October 6, 1987. Estimated Expiration Date: 
May 20, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 20, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorAssigneeApplicationNo. 06/830717 filed on 05/20/1986US Classes:514/253.04, Bicyclo ring having the additional six-membered nitrogen hetero ring as one of the cyclos514/277, Hetero ring is six-membered consisting of one nitrogen and five carbon atoms514/282, One of the five cyclos is five-membered and includes ring chalcogen (e.g., codeine, morphine, etc.)514/419, C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen)514/479With an additional active ingredientExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassA61K 31/495 (20060101)AbstractCompositions are disclosed for controlling pain, depression, and sedation. The compositions comprise a serotonin precursor such as L-tryptophan or L-5-hydroxytryptophan in combination with a serotonin-specific reuptake inhibitor such as trazodone. In a preferred embodiment, the compositions are coadministered with a narcotic, the composition substantially potentiating the analgesic effect of the narcotic.Other References
Field of SearchHetero ring is six-membered consisting of one nitrogen and five carbon atomsOne of the five cyclos is five-membered and includes ring chalcogen (e.g., codeine, morphine, etc.) C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen) Ascorbic acid or derivative (e.g., vitamin C, etc.) | |
